ClinicalTrials.Veeva

Menu

Validation of a Diagnostic Score for Encephalitis to Assess the Risk of Autoimmune Origin (Val-Dia score)

Civil Hospices of Lyon logo

Civil Hospices of Lyon

Status

Active, not recruiting

Conditions

Autoimmune Encephalitis Caused by N-Methyl D-Aspartate Receptor Antibody (Disorder)
Autoimmune Encephalitis

Treatments

Other: Clinical score of Granillo and al.

Study type

Observational

Funder types

Other

Identifiers

NCT05953974
69HCL23_0627

Details and patient eligibility

About

The investigators wish to test a diagnostic risk score for autoimmune encephalitis in case of encephalitis, previously validated by two American teams, in a retrospective analysis, according to the clinical and paraclinical data available in our database of the Reference Centre for Autoimmune Encephalitis and Paraneoplastic Neurological Syndromes of Professor Honnorat for patients with NMDAr, anti LGi1, anti CASPR2, anti GABAbr and anti GAD antibodies.

Enrollment

350 estimated patients

Sex

All

Ages

18+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Age > 18 years old
  • Patient with a definite auto-immune encephalitis (Graus and al. 2016)

Exclusion criteria

  • Uncomplete data in acute phase
  • Patient with several antibodies
  • Opposition

Trial design

350 participants in 5 patient groups

NMDAr patients
Description:
Patients \> or = 18 years old presenting with auto-immune encephalitis, defined according to the Graus criteria, with neuronal antibodies : - Anti NMDAr
Treatment:
Other: Clinical score of Granillo and al.
LGI1 patients
Description:
Patients \> or = 18 years old presenting with auto-immune encephalitis, defined according to the Graus criteria, with neuronal antibodies : - Anti LGI1
Treatment:
Other: Clinical score of Granillo and al.
CASPR2 patients
Description:
Patients \> or = 18 years old presenting with auto-immune encephalitis, defined according to the Graus criteria, with neuronal antibodies : - Anti CASPR2
Treatment:
Other: Clinical score of Granillo and al.
GABAb patients
Description:
Patients \> or = 18 years old presenting with auto-immune encephalitis, defined according to the Graus criteria, with neuronal antibodies : - Anti GABAb
Treatment:
Other: Clinical score of Granillo and al.
GAD patients
Description:
Patients \> or = 18 years old presenting with auto-immune encephalitis, defined according to the Graus criteria, with neuronal antibodies : - Anti GAD
Treatment:
Other: Clinical score of Granillo and al.

Trial contacts and locations

1

Loading...

Central trial contact

Marie Benaiteau, Dr; Marine Villard

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems